The at-home fertility hormone patch market size has grown rapidly in recent years. It will grow from $0.59 billion in 2025 to $0.68 billion in 2026 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to increasing infertility rates, growth of home diagnostic devices, rising awareness of reproductive health, expansion of digital health platforms, early adoption of wearable biosensors.
The at-home fertility hormone patch market size is expected to see rapid growth in the next few years. It will grow to $1.21 billion in 2030 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to AI-enabled hormone analytics, increasing demand for personalized fertility planning, growing focus on preventive reproductive healthcare, rising use of connected health devices, expansion of tele-fertility services. Major trends in the forecast period include rising adoption of non-invasive fertility monitoring, increased demand for at-home reproductive health solutions, growing acceptance of wearable hormone tracking devices, expansion of female-centric health technologies, shift toward personalized fertility insights.
The increasing prevalence of infertility is expected to drive the growth of the at-home fertility hormone patch market. Infertility is defined as the inability to achieve pregnancy after 12 months of regular unprotected intercourse, or difficulties in conceiving or carrying a pregnancy to term. Its prevalence is rising due to delayed childbearing, as more individuals postpone family planning to later reproductive years, when age-related declines in egg quality, ovarian reserve, and sperm parameters reduce conception success rates. The growing burden of infertility boosts demand for at-home fertility hormone testing solutions, as these patches allow convenient, non-invasive monitoring of reproductive hormones, helping individuals track ovulation, identify fertile windows, and make informed reproductive health decisions without frequent clinic visits. For example, in April 2023, the World Health Organization reported that approximately 17.5% of adults globally, or about 1 in 6 people, face infertility, highlighting the urgent need for accessible, high-quality fertility care. The rising prevalence of infertility is therefore driving market growth.
Increasing investment in women's health initiatives is expected to propel the at-home fertility hormone patch market. Women's health initiatives include programs, policies, and campaigns aimed at improving physical, mental, and reproductive health. Investment is increasing due to recognition of historical healthcare disparities, where women's health concerns have often been overlooked, resulting in fragmented services and poor outcomes. Funding in women’s health supports innovations such as at-home fertility hormone patches by promoting research, improving accessibility, and addressing gaps in reproductive healthcare, empowering women to monitor and manage fertility safely at home. For instance, in March 2025, the UK Department of Health and Social Care allocated $32 million (approximately £25 million) between financial years 2023-2024 and 2024-2025 to establish women’s health hubs as a proof of concept. Growing investment in women’s health initiatives is thus driving market growth.
Major companies in the at-home fertility hormone patch market are developing next-generation solutions, including DNA-based wearable patches for real-time, non-invasive hormone tracking. DNA-based wearable patches use DNA-derived sensors to detect hormone levels in interstitial fluid, allowing users to monitor hormonal fluctuations continuously without invasive blood tests, supporting fertility tracking and overall hormonal health. For example, in February 2025, Level Zero Health Inc., a UK biotechnology company, raised $6.9 million in an oversubscribed pre-seed funding round to develop the world’s first continuous hormone monitoring patch. The DNA-based wearable patch measures hormones such as cortisol, progesterone, estrogen, and testosterone in interstitial fluid, providing real-time insights for fertility tracking, hormonal health management, and remote clinical monitoring. This arm-worn, non-invasive device reduces the need for clinic visits and invasive procedures. The company initially targets B2B clinical applications, including fertility clinics and endocrine treatment centers, with plans to expand into consumer-focused wellness markets.
Major companies operating in the at-home fertility hormone patch market are Level Zero Health, Persperity Health, Muun Health, Epicore Biosystems, Impli, POM Health, Eli Health, Mira, Oova, Symex Labs, Arva Health, Ava Science Inc., Tempdrop, Inito, Proov, Hormona, Kegg, Femometer, Fairhaven Health, Ovia Health.
North America was the largest region in the at-home fertility hormone patch market in 2025. The regions covered in the at-home fertility hormone patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the at-home fertility hormone patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the at-home fertility hormone patch market by increasing costs of imported biosensors, electronic components, and wearable-grade materials used in hormone detection patches. The impact is most visible across reusable and smart patch segments, particularly in North America and Asia-Pacific where component sourcing is highly globalized. At the same time, tariffs have encouraged manufacturers to localize production, invest in regional supply chains, and develop cost-efficient single-use and reusable patch designs, supporting long-term market stability.
The at-home fertility hormone patch market research report is one of a series of new reports that provides at-home fertility hormone patch market statistics, including at-home fertility hormone patch industry global market size, regional shares, competitors with a at-home fertility hormone patch market share, detailed at-home fertility hormone patch market segments, market trends and opportunities, and any further data you may need to thrive in the at-home fertility hormone patch industry. This at-home fertility hormone patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An at-home fertility hormone patch is a wearable device designed to monitor fertility-related hormone levels through the skin. It noninvasively collects biological data and transmits it to a connected platform for analysis. The technology enables convenient tracking of hormonal changes and identification of fertility patterns at home, providing valuable insights into reproductive health and assisting in predicting fertile windows for improved family planning or fertility management.
The primary product types of at-home fertility hormone patches are single-use patches and reusable patches. A single-use patch is a disposable, sterile medical device intended for one-time, single-patient use, offering simple, hygienic, and maintenance-free hormone tracking at home. These patches monitor hormones such as estrogen, progesterone, luteinizing hormone, follicle-stimulating hormone, and others. They are distributed through multiple channels, including online pharmacies, retail pharmacies, supermarkets or hypermarkets, and more. The patches are used for applications such as female and male fertility testing and are utilized by end-users including home care, clinics, hospitals, and others.
The at-home fertility hormone patch market consists of sales of multi-hormone tracking patches, temperature and hormone combination patches, estrogen delivery patches, progesterone delivery patches, follicle-stimulating hormone (FSH) micro-needle patches, combination hormone therapy patches, smart fertility tracking patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The at-home fertility hormone patch market size is expected to see rapid growth in the next few years. It will grow to $1.21 billion in 2030 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to AI-enabled hormone analytics, increasing demand for personalized fertility planning, growing focus on preventive reproductive healthcare, rising use of connected health devices, expansion of tele-fertility services. Major trends in the forecast period include rising adoption of non-invasive fertility monitoring, increased demand for at-home reproductive health solutions, growing acceptance of wearable hormone tracking devices, expansion of female-centric health technologies, shift toward personalized fertility insights.
The increasing prevalence of infertility is expected to drive the growth of the at-home fertility hormone patch market. Infertility is defined as the inability to achieve pregnancy after 12 months of regular unprotected intercourse, or difficulties in conceiving or carrying a pregnancy to term. Its prevalence is rising due to delayed childbearing, as more individuals postpone family planning to later reproductive years, when age-related declines in egg quality, ovarian reserve, and sperm parameters reduce conception success rates. The growing burden of infertility boosts demand for at-home fertility hormone testing solutions, as these patches allow convenient, non-invasive monitoring of reproductive hormones, helping individuals track ovulation, identify fertile windows, and make informed reproductive health decisions without frequent clinic visits. For example, in April 2023, the World Health Organization reported that approximately 17.5% of adults globally, or about 1 in 6 people, face infertility, highlighting the urgent need for accessible, high-quality fertility care. The rising prevalence of infertility is therefore driving market growth.
Increasing investment in women's health initiatives is expected to propel the at-home fertility hormone patch market. Women's health initiatives include programs, policies, and campaigns aimed at improving physical, mental, and reproductive health. Investment is increasing due to recognition of historical healthcare disparities, where women's health concerns have often been overlooked, resulting in fragmented services and poor outcomes. Funding in women’s health supports innovations such as at-home fertility hormone patches by promoting research, improving accessibility, and addressing gaps in reproductive healthcare, empowering women to monitor and manage fertility safely at home. For instance, in March 2025, the UK Department of Health and Social Care allocated $32 million (approximately £25 million) between financial years 2023-2024 and 2024-2025 to establish women’s health hubs as a proof of concept. Growing investment in women’s health initiatives is thus driving market growth.
Major companies in the at-home fertility hormone patch market are developing next-generation solutions, including DNA-based wearable patches for real-time, non-invasive hormone tracking. DNA-based wearable patches use DNA-derived sensors to detect hormone levels in interstitial fluid, allowing users to monitor hormonal fluctuations continuously without invasive blood tests, supporting fertility tracking and overall hormonal health. For example, in February 2025, Level Zero Health Inc., a UK biotechnology company, raised $6.9 million in an oversubscribed pre-seed funding round to develop the world’s first continuous hormone monitoring patch. The DNA-based wearable patch measures hormones such as cortisol, progesterone, estrogen, and testosterone in interstitial fluid, providing real-time insights for fertility tracking, hormonal health management, and remote clinical monitoring. This arm-worn, non-invasive device reduces the need for clinic visits and invasive procedures. The company initially targets B2B clinical applications, including fertility clinics and endocrine treatment centers, with plans to expand into consumer-focused wellness markets.
Major companies operating in the at-home fertility hormone patch market are Level Zero Health, Persperity Health, Muun Health, Epicore Biosystems, Impli, POM Health, Eli Health, Mira, Oova, Symex Labs, Arva Health, Ava Science Inc., Tempdrop, Inito, Proov, Hormona, Kegg, Femometer, Fairhaven Health, Ovia Health.
North America was the largest region in the at-home fertility hormone patch market in 2025. The regions covered in the at-home fertility hormone patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the at-home fertility hormone patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the at-home fertility hormone patch market by increasing costs of imported biosensors, electronic components, and wearable-grade materials used in hormone detection patches. The impact is most visible across reusable and smart patch segments, particularly in North America and Asia-Pacific where component sourcing is highly globalized. At the same time, tariffs have encouraged manufacturers to localize production, invest in regional supply chains, and develop cost-efficient single-use and reusable patch designs, supporting long-term market stability.
The at-home fertility hormone patch market research report is one of a series of new reports that provides at-home fertility hormone patch market statistics, including at-home fertility hormone patch industry global market size, regional shares, competitors with a at-home fertility hormone patch market share, detailed at-home fertility hormone patch market segments, market trends and opportunities, and any further data you may need to thrive in the at-home fertility hormone patch industry. This at-home fertility hormone patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An at-home fertility hormone patch is a wearable device designed to monitor fertility-related hormone levels through the skin. It noninvasively collects biological data and transmits it to a connected platform for analysis. The technology enables convenient tracking of hormonal changes and identification of fertility patterns at home, providing valuable insights into reproductive health and assisting in predicting fertile windows for improved family planning or fertility management.
The primary product types of at-home fertility hormone patches are single-use patches and reusable patches. A single-use patch is a disposable, sterile medical device intended for one-time, single-patient use, offering simple, hygienic, and maintenance-free hormone tracking at home. These patches monitor hormones such as estrogen, progesterone, luteinizing hormone, follicle-stimulating hormone, and others. They are distributed through multiple channels, including online pharmacies, retail pharmacies, supermarkets or hypermarkets, and more. The patches are used for applications such as female and male fertility testing and are utilized by end-users including home care, clinics, hospitals, and others.
The at-home fertility hormone patch market consists of sales of multi-hormone tracking patches, temperature and hormone combination patches, estrogen delivery patches, progesterone delivery patches, follicle-stimulating hormone (FSH) micro-needle patches, combination hormone therapy patches, smart fertility tracking patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. At-Home Fertility Hormone Patch Market Characteristics
3. At-Home Fertility Hormone Patch Market Supply Chain Analysis
4. Global At-Home Fertility Hormone Patch Market Trends and Strategies
5. At-Home Fertility Hormone Patch Market Analysis of End Use Industries
7. Global At-Home Fertility Hormone Patch Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global At-Home Fertility Hormone Patch Total Addressable Market (TAM) Analysis for the Market
9. At-Home Fertility Hormone Patch Market Segmentation
10. At-Home Fertility Hormone Patch Market Regional and Country Analysis
11. Asia-Pacific At-Home Fertility Hormone Patch Market
12. China At-Home Fertility Hormone Patch Market
13. India At-Home Fertility Hormone Patch Market
14. Japan At-Home Fertility Hormone Patch Market
15. Australia At-Home Fertility Hormone Patch Market
16. Indonesia At-Home Fertility Hormone Patch Market
17. South Korea At-Home Fertility Hormone Patch Market
18. Taiwan At-Home Fertility Hormone Patch Market
19. South East Asia At-Home Fertility Hormone Patch Market
20. Western Europe At-Home Fertility Hormone Patch Market
21. UK At-Home Fertility Hormone Patch Market
22. Germany At-Home Fertility Hormone Patch Market
23. France At-Home Fertility Hormone Patch Market
24. Italy At-Home Fertility Hormone Patch Market
25. Spain At-Home Fertility Hormone Patch Market
26. Eastern Europe At-Home Fertility Hormone Patch Market
27. Russia At-Home Fertility Hormone Patch Market
28. North America At-Home Fertility Hormone Patch Market
29. USA At-Home Fertility Hormone Patch Market
30. Canada At-Home Fertility Hormone Patch Market
31. South America At-Home Fertility Hormone Patch Market
32. Brazil At-Home Fertility Hormone Patch Market
33. Middle East At-Home Fertility Hormone Patch Market
34. Africa At-Home Fertility Hormone Patch Market
36. At-Home Fertility Hormone Patch Market Competitive Landscape and Company Profiles
37. At-Home Fertility Hormone Patch Market Other Major and Innovative Companies
40. At-Home Fertility Hormone Patch Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
At-Home Fertility Hormone Patch Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses at-home fertility hormone patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for at-home fertility hormone patch? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The at-home fertility hormone patch market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Single-Use Patch; Reusable Patch2) By Hormone Type: Estrogen; Progesterone; Luteinizing Hormone; Follicle-Stimulating Hormone; Other Hormone Types
3) By Distribution Channel: Online Pharmacies; Retail Pharmacies; Supermarkets Or Hypermarkets; Other Distribution Channels
4) By Application: Female Fertility Testing; Male Fertility Testing
5) By End-User: Home Care; Clinics; Hospitals; Other End Users
Subsegments:
1) By Single-Use Patch: Disposable Fertility Hormone Patches; One-Time Ovulation Monitoring Patches; Single-Cycle Hormone Tracking Patches; Adhesive Single-Use Hormone Detection Patches2) By Reusable Patch: Multi-Cycle Fertility Hormone Patches; Rechargeable Hormone Monitoring Patches; Long-Term Wearable Hormone Tracking Patches; Smart Reusable Hormone Patches
Companies Mentioned: Level Zero Health; Persperity Health; Muun Health; Epicore Biosystems; Impli; POM Health; Eli Health; Mira; Oova; Symex Labs; Arva Health; Ava Science Inc.; Tempdrop; Inito; Proov; Hormona; Kegg; Femometer; Fairhaven Health; Ovia Health
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this At-Home Fertility Hormone Patch market report include:- Level Zero Health
- Persperity Health
- Muun Health
- Epicore Biosystems
- Impli
- POM Health
- Eli Health
- Mira
- Oova
- Symex Labs
- Arva Health
- Ava Science Inc.
- Tempdrop
- Inito
- Proov
- Hormona
- Kegg
- Femometer
- Fairhaven Health
- Ovia Health
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.68 Billion |
| Forecasted Market Value ( USD | $ 1.21 Billion |
| Compound Annual Growth Rate | 15.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
